Skip to main content

Athersys, Inc

ATHXDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001368148

Athersys, Inc was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 21, 2023; 43 institutions reported holding it in 13F filings for Q3 2023, worth $1.18M in total; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding Athersys, Inc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of ATHX: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders714−2
Shares275.7K274.7K729−261 (−26.4%)
Value$5.51K$5.50K$5−$13 (−72.2%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (0)

Institutions that held Athersys, Inc at the end of Q1 2024 but not at the end of Q4 2023.

None.

Sold out (2)

Institutions that held Athersys, Inc at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of ATHX in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Arlington Partners LLC250$5
Fairman Group, LLC11$0

Not filed for Q1 2024 yet (1)

Institutions that held Athersys, Inc at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ATHX in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Strategic Wealth Designers274,738$5.50K